Human CRTAC1/ASPIC/ASPIC1 ORF/cDNA clone-Lentivirus particle (NM_018058)
Cat. No.: vGMLP004226
Pre-made Human CRTAC1/ASPIC/ASPIC1 Lentiviral expression plasmid for CRTAC1 lentivirus packaging, CRTAC1 lentivirus production, overexpression stable cell line development, cell transient transfection and gene delivery targeting T/B/NK cells, macrophages, cardiomyocytes, hepatocytes, and neurons.
The GM Vector Core (GMVC) specializes in custom lentivirus development and offers a range of lentivirus manufacturing solutions, leveraging state-of-the-art processes. Learn more about our services.
Go to
CRTAC1/ASPIC products
collection>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Catalog No. | Product Name | lentivirus Grade | lentivirus quantity |
---|---|---|---|
vGMLP004226 | Human CRTAC1 Lentivirus particle | Pilot Grade | 1.0E+8TU |
5.0E+8TU | |||
1.0E+9TU | |||
Research Grade | 1.0E+8TU | ||
5.0E+8TU | |||
1.0E+9TU | |||
GMP-like Grade | inquiry | ||
GMP Grade | inquiry |
Product Description
Catalog ID | vGMLP004226 |
Gene Name | CRTAC1 |
Accession Number | NM_018058 |
Gene ID | 55118 |
Species | Human |
Product Type | Lentivirus particle (overexpression) |
Insert Length | 1986 bp |
Gene Alias | ASPIC,ASPIC1,CEP-68 |
Fluorescent Reporter | ZsGreen |
Mammalian Cell Selection | Puromyocin |
Fusion Tag | 3xflag (C-Terminal) |
Promoter | CMV |
Resistance | Amplicin |
ORF Nucleotide Sequence | ATGGCTCCGAGCGCTGACCCCGGCATGTCCAGGATGTTACCGTTCCTGCTGCTGCTCTGGTTTCTGCCCATCACTGAGGGGTCCCAGCGGGCTGAACCCATGTTCACTGCAGTCACCAACTCAGTTCTGCCTCCTGACTATGACAGTAATCCCACCCAGCTCAACTATGGTGTGGCAGTTACTGATGTGGACCATGATGGGGACTTTGAGATCGTCGTGGCGGGGTACAATGGACCCAACCTGGTTCTGAAGTATGACCGGGCCCAGAAGCGGCTGGTGAACATCGCGGTCGATGAGCGCAGCTCACCCTACTACGCGCTGCGGGACCGGCAGGGGAACGCCATCGGGGTCACAGCCTGCGACATCGACGGGGACGGCCGGGAGGAGATCTACTTCCTCAACACCAATAATGCCTTCTCGGGGGTGGCCACGTACACCGACAAGTTGTTCAAGTTCCGCAATAACCGGTGGGAAGACATCCTGAGCGATGAGGTCAACGTGGCCCGTGGTGTGGCCAGCCTCTTTGCCGGACGCTCTGTGGCCTGTGTGGACAGAAAGGGCTCTGGACGCTACTCTATCTACATTGCCAATTACGCCTACGGTAATGTGGGCCCTGATGCCCTCATTGAAATGGACCCTGAGGCCAGTGACCTCTCCCGGGGCATTCTGGCGCTCAGAGATGTGGCTGCTGAGGCTGGGGTCAGCAAATATACAGGGGGCCGAGGCGTCAGCGTGGGCCCCATCCTCAGCAGCAGTGCCTCGGATATCTTCTGCGACAATGAGAATGGGCCTAACTTCCTTTTCCACAACCGGGGCGATGGCACCTTTGTGGACGCTGCGGCCAGTGCTGGTGTGGACGACCCCCACCAGCATGGGCGAGGTGTCGCCCTGGCTGACTTCAACCGTGATGGCAAAGTGGACATCGTCTATGGCAACTGGAATGGCCCCCACCGCCTCTATCTGCAAATGAGCACCCATGGGAAGGTCCGCTTCCGGGACATCGCCTCACCCAAGTTCTCCATGCCCTCCCCTGTCCGCACGGTCATCACCGCCGACTTTGACAATGACCAGGAGCTGGAGATCTTCTTCAACAACATTGCCTACCGCAGCTCCTCAGCCAACCGCCTCTTCCGCGTCATCCGTAGAGAGCACGGAGACCCCCTCATCGAGGAGCTCAATCCCGGCGACGCCTTGGAGCCTGAGGGCCGGGGCACAGGGGGTGTGGTGACCGACTTCGACGGAGACGGGATGCTGGACCTCATCTTGTCCCATGGAGAGTCCATGGCTCAGCCGCTGTCCGTCTTCCGGGGCAATCAGGGCTTCAACAACAACTGGCTGCGAGTGGTGCCACGCACCCGGTTTGGGGCCTTTGCCAGGGGAGCTAAGGTCGTGCTCTACACCAAGAAGAGTGGGGCCCACCTGAGGATCATCGACGGGGGCTCAGGCTACCTGTGTGAGATGGAGCCCGTGGCACACTTTGGCCTGGGGAAGGATGAAGCCAGCAGTGTGGAGGTGACGTGGCCAGATGGCAAGATGGTGAGCCGGAACGTGGCCAGCGGGGAGATGAACTCAGTGCTGGAGATCCTCTACCCCCGGGATGAGGACACACTTCAGGACCCAGCCCCACTGGAGTGTGGCCAAGGATTCTCCCAGCAGGAAAATGGCCATTGCATGGACACCAATGAATGCATCCAGTTCCCATTCGTGTGCCCTCGAGACAAGCCCGTATGTGTCAACACCTATGGAAGCTACAGGTGCCGGACCAACAAGAAGTGCAGTCGGGGCTACGAGCCCAACGAGGATGGCACAGCCTGCGTGGGGACTCTCGGCCAGTCACCGGGCCCCCGCCCCACCACCCCCACCGCTGCTGCTGCCACTGCCGCTGCTGCTGCCGCTGCTGGAGCTGCCACTGCTGCACCGGTCCTCGTAGATGGAGATCTCAATCTGGGGTCGGTGGTTAAGGAGAGCTGCGAGCCCAGCTGCTGA |
ORF Protein Sequence | MAPSADPGMSRMLPFLLLLWFLPITEGSQRAEPMFTAVTNSVLPPDYDSNPTQLNYGVAVTDVDHDGDFEIVVAGYNGPNLVLKYDRAQKRLVNIAVDERSSPYYALRDRQGNAIGVTACDIDGDGREEIYFLNTNNAFSGVATYTDKLFKFRNNRWEDILSDEVNVARGVASLFAGRSVACVDRKGSGRYSIYIANYAYGNVGPDALIEMDPEASDLSRGILALRDVAAEAGVSKYTGGRGVSVGPILSSSASDIFCDNENGPNFLFHNRGDGTFVDAAASAGVDDPHQHGRGVALADFNRDGKVDIVYGNWNGPHRLYLQMSTHGKVRFRDIASPKFSMPSPVRTVITADFDNDQELEIFFNNIAYRSSSANRLFRVIRREHGDPLIEELNPGDALEPEGRGTGGVVTDFDGDGMLDLILSHGESMAQPLSVFRGNQGFNNNWLRVVPRTRFGAFARGAKVVLYTKKSGAHLRIIDGGSGYLCEMEPVAHFGLGKDEASSVEVTWPDGKMVSRNVASGEMNSVLEILYPRDEDTLQDPAPLECGQGFSQQENGHCMDTNECIQFPFVCPRDKPVCVNTYGSYRCRTNKKCSRGYEPNEDGTACVGTLGQSPGPRPTTPTAAAATAAAAAAAGAATAAPVLVDGDLNLGSVVKESCEPSC |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
Category | Cat No. | Products Name |
---|---|---|
Target Antibody | GM-Tg-g-SE0825-Ab | Anti-CRAC1/ CRTAC1/ ASPIC functional antibody |
Target Antigen | GM-Tg-g-SE0825-Ag | CRTAC1 protein |
ORF Viral Vector | pGMLP004226 | Human CRTAC1 Lentivirus plasmid |
ORF Viral Vector | vGMLP004226 | Human CRTAC1 Lentivirus particle |
Target information
Target ID | GM-SE0825 |
Target Name | CRTAC1 |
Gene ID | 55118, 72832, 707486, 171438, 101082013, 608827, 100139581, 100060874 |
Gene Symbol and Synonyms | 2810454P21Rik,ASPIC,ASPIC1,CEP-68,CEP68,CRTAC1,Crtac1B,LOTUS,W307 |
Uniprot Accession | Q9NQ79 |
Uniprot Entry Name | CRAC1_HUMAN |
Protein Sub-location | Secreted Protein/Potential Cytokines |
Category | Not Available |
Disease | Prostate Cancer |
Gene Ensembl | ENSG00000095713 |
Target Classification | Not Available |
This gene encodes a glycosylated extracellular matrix protein that is found in the interterritorial matrix of articular deep zone cartilage. This protein is used as a marker to distinguish chondrocytes from osteoblasts and mesenchymal stem cells in culture. The presence of FG-GAP motifs and an RGD integrin-binding motif suggests that this protein may be involved in cell-cell or cell-matrix interactions. Copy number alterations in this gene have been observed in neurofibromatosis type 1-associated glomus tumors. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2011]
About GMVC
GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.